Hunan Warrant Pharmaceutical Co.,Ltd (SHSE: 688799)
Health Care · Pharmaceuticals · CN
CN¥43.65
-1.18% today · -13.4% 1Y
Hunan Warrant Pharmaceutical Co.,Ltd (SHSE: 688799) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $867.73M and employs 1,291 people.
Over the last twelve months the share price has lost 13.4%, trading between 40.33 and 66.88.
Tweenvest scores Hunan Warrant Pharmaceutical Co.,Ltd across four factors: quality 66/100, value 33/100, growth 71/100, dividend 35/100. Its strongest factor is growth.
688799 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $867.73M
- Revenue (TTM)
- $216.39M
- P/E
- 26.31
- EPS
- 1.66
- Dividend yield
- 0.41%
- Beta (5Y)
- 0.18
- 52-week high
- CN¥66.88
- 52-week low
- CN¥40.33
- Avg volume (3M)
- —
- Shares outstanding
- 133.64M
- Employees
- 1,291
- Next earnings
- —
About Hunan Warrant Pharmaceutical Co.,Ltd
Hunan Warrant Pharmaceutical Co., Ltd. is engaged in the manufacturing and commercialization of pharmaceutical products. Its extensive product line encompasses treatments addressing immune and kidney-related conditions, obstetrics and gynecology, cardiovascular health, and digestive system issues. The company also offers a range of anti-infective medications and remedies for various other ailments. Established in 2001, it is headquartered in Changsha, China.
- ISIN
- CNE100004P73
- Founded
- 2001
- Listed since
- Jul 13, 2021
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | 0.00% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.18 | +0.01% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.24 | -0.13% |
| Roche Holding AGSWX: ROP | $371.62B | CHF370.90 | -0.78% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.18 | -1.27% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.52 | -0.18% |
Figures last refreshed Aug 18, 2026.